Martins, M. V., Lorenzo, P. D., Kotecha, R. S., Attarbaschi, A., Escherich, G., Nysom, K., Stary, J., Ferster, A., Brethon, B., Locatelli, F., Schrappe, M., Houtem, P. E. S., Valsecchi, M. G., Huitema, A. D., Pieters, R., Sluis, I. M. V. D. (2026). Sustained Benefit of Blinatumomab in Infants With
                    <i>KMT2A</i>
                    -Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01806